Newsroom | 2228 results

Sorted by: Latest

Biometrics
-

ŌURA Named Official Wearable of Team Finland

SAN FRANCISCO--(BUSINESS WIRE)--ŌURA, maker of the world’s leading smart ring, Oura Ring, today announced a long-term partnership as the Official Wearable of Team Finland. As the exclusive provider in the category of continuous health and fitness tracking devices, ŌURA will equip Team Finland Olympic athletes with Oura Ring beginning immediately and continuing through the LA28 Olympic Games and the French Alps 2030 Winter Games. Team Finland delivered a strong showing on the world stage at the...
-

Shufti setzt eine neue Benchmark für VideoIdent im DACH-Markt

London, Vereinigtes Königreich--(BUSINESS WIRE)--Shufti, ein globaler Anbieter von Identitätsverifizierungs- und Compliance-Technologien, gab die Ausweitung seiner VideoIdent-Lösung auf Deutschland, Österreich und die Schweiz (DACH-Region) bekannt. Die Initiative adressiert operative Belastungspunkte, mit denen Banken, Zahlungsdienstleister und FinTechs im VideoIdent-Verfahren zunehmend konfrontiert sind – darunter verlängerte Wartezeiten in Warteschlangen, begrenzte Sprachverfügbarkeit, starre...
-

Shufti Sets a New Benchmark for VideoIdent in the DACH Market

LONDON--(BUSINESS WIRE)--Shufti, a global identity verification and compliance technology provider announced the expansion of its VideoIdent solution across Germany, Austria, and Switzerland (DACH region), addressing the operational pressure points that banks, payment providers, and fintechs increasingly face in VideoIdent including prolonged queue waiting times, limited language availability, rigid KYC agent interactions, and avoidable session drop-offs during technical interruptions. In DACH...
-

Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study

SAN ANTONIO, Texas--(BUSINESS WIRE)--bioAffinity Technologies shares a new case study that demonstrates how CyPath® Lung supports clinical decision-making in high-risk patients....
-

Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $878 million for the fourth quarter of 2025 and $3.25 billion for the full year of 2025, both ended December 31, 2025. “In 2025 the Exact Sciences team delivered on our mission by screening more people than ever before, helping guide more personalized treatment decisions, and successfully launching three new tests...
-

iProov Dynamic Liveness Is the First and Only Solution to Achieve CEN/TS 18099 High and Ingenium Level 4 for Injection Attack Detection

LONDON--(BUSINESS WIRE)--iProov Dynamic Liveness is the first to achieve CEN/TS 18099 High and Ingenium Level 4 for injection attack detection...
-

Owlet Announces Strategic DME Partnership with PromptCare to Expand Distribution of Pediatric Pulse Oximeter, BabySat®

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a new strategic partnership with PromptCare, a leading national respiratory services and durable medical equipment (DME) provider specializing in adult and pediatric care. The partnership expands Owlet’s clinical and DME footprint across key U.S. regions and supports broader access to the Company’s FDA-cleared, prescription pulse oximeter, BabySat, through es...
-

Riassunto: Eurofins Viracor BioPharma amplia le proprie capacità bioanalitiche

LUSSEMBURGO--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, partner di lunga data e affidabile per le soluzioni di studi clinici con una vasta esperienza nell'ambito di biomarcatori specifici e test molecolari, ha annunciato un'importante espansione del proprio portafoglio di servizi con l'aggiunta di capacità migliorate di test bioanalitici. Questi nuovi servizi sono in completa sintonia con le buone pratiche di laboratorio (GLP) e le buone pratiche cliniche (GCP), e consentiranno all'a...
-

Eurofins Viracor BioPharma erweitert bioanalytische Fähigkeiten

LUXEMBURG--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, ein langjähriger und bewährter Partner für klinische Testlösungen mit fundierter Expertise in den Bereichen Spezialbiomarker und molekulare Assays, gibt eine bedeutende Erweiterung seines Serviceportfolios um zusätzliche bioanalytische Testkapazitäten bekannt. Diese neuen Serviceleistungen erfüllen die GLP- (Good Laboratory Practices) und GCP-Anforderungen (Good Clinical Practices) und helfen Unternehmen, die Unterstützung von bio...
-

Eurofins Viracor BioPharma étoffe ses capacités bioanalytiques

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, partenaire de longue date et de confiance dans le domaine des solutions de tests cliniques, jouissant d'une expertise approfondie dans les biomarqueurs spécialisés et les tests moléculaires, annonce une expansion significative de son portefeuille de services avec l'ajout de capacités de tests bioanalytiques améliorées. Ces nouveaux services s'inscrivent pleinement dans le cadre des bonnes pratiques de laboratoire (BPL) et des bon...